Get started
Author

Montserrat Marqués-Pamies

Observed names: M. Marques-Pamies, Marques, Montserrat, Marqués Pamies, Montserrat, Marqués-Pamies, Montserrat, Montse Marques-Pamies, Montse Marqués, Montserrat MARQUES-PAMIES, Montserrat Marques-Pamies, Montserrat Marques‐Pamies
ORCID: 0000-0001-6391-5070
Observed ORCID: 0000-0001-6391-5070
OpenAlex ID: A5064287441
Molecular profiling for acromegaly treatment: a validation study
2020 · Manel Puig-Domingo, Joan Gil, et al. · Endocrine Related Cancer · 75
PDF
Pasireotide in the Personalized Treatment of Acromegaly
2021 · Manel Puig-Domingo, Ignacio Bernabéu, et al. · Frontiers in Endocrinology · 64
Personalized Medicine in Acromegaly: The ACROFAST Study
2024 · Montserrat Marques-Pamies, Joan Gil, et al. · The Journal of Clinical Endocrinology & Metabolism · 34
PDF
Data mining analyses for precision medicine in acromegaly: a proof of concept
2022 · Joan Gil, Montserrat Marques-Pamies, et al. · Scientific Reports · 31
PDF
Predictors of biochemical response to somatostatin receptor ligands in acromegaly
2024 · Mónica Marazuela, Rebeca Martínez-Hernandez, et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 24
PDF
Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly
2023 · Montserrat Marques-Pamies, Joan Gil, et al. · Archives of Medical Research · 21
PDF
Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution
2020 · Sofia España, Alejandra Pérez Montes de Oca, et al. · Translational Lung Cancer Research · 17
PDF
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
2022 · Joan Gil, Montserrat Marques-Pamies, et al. · Biomedicines · 16
PDF
Acromegaly facial changes analysis using last generation artificial intelligence methodology: the AcroFace system
2025 · Hatem A. Rashwan, Montserrat Marqués-Pamies, et al. · Pituitary · 15
PDF
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH‐producing adenomas
2020 · Joan Gil, Montserrat Marques‐Pamies, et al. · Clinical Endocrinology · 14
New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”
2020 · Ana de Hollanda, Albert Lecube, et al. · Journal of Clinical Medicine · 13
PDF
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
2024 · Miguel Sampedro-Nuñez, Aura Dulcinea Herrera-Martínez, et al. · European Journal of Endocrinology · 11
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
2023 · Montserrat Marques-Pamies, Joan Gil, et al. · Frontiers in Endocrinology · 11
PDF
Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
2023 · Joan Gil, Montserrat Marques-Pamies, et al. · Frontiers in Endocrinology · 11
PDF
New molecular tools for precision medicine in pituitary neuroendocrine tumors
2024 · Montserrat MARQUES-PAMIES, Joan GIL, et al. · Minerva Endocrinology · 7
PDF
Quality of life and psychological status in people with acromegaly in relation to disease-related facial changes
2025 · Maria Antonia Martínez-Momblán, Sergio Alonso-Fernández, et al. · Endocrine Connections · 5
PDF
Differential Behavior of 25(OH)D and f25(OH)D3 in Patients with Morbid Obesity After Bariatric Surgery
2021 · Montserrat Marques-Pamies, María López-Molina, et al. · Obesity Surgery · 4
Molecular profiling for assistance to pharmacological treatment of acromegaly
2018 · Manuel Puig-Domingo, Joan Gil, et al. · Endocrine Abstracts · 4
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
2026 · Montserrat Marques-Pamies, Laura Ricou, et al. · Journal of the Endocrine Society · 3
Usefulness of the short version of the acute octreotide test for prediction of first-generation somatostatin receptor ligands response in acromegaly: a validation study with the ACROFAST cohort
2023 · Montserrat Marques-Pamies, Joan Gil, et al. · Endocrine Abstracts · 2
Approach to the patient: precision medicine–guided evaluation and treatment of acromegaly
2026 · Manel Puig-Domingo, Montserrat Marques-Pamies, et al. · The Journal of Clinical Endocrinology & Metabolism · 1
MRI-based radiomics prediction of somatostatin receptor ligand response in acromegaly: an automated pipeline study
2026 · Sabina Ruiz, Roger Mateu-Estivill, et al. · Journal of the Endocrine Society
PDF
Quality of Life in Acromegaly: Results From the ACROFAST Study
2026 · Montserrat Marques-Pamies, Miguel Sampedro-Núñez, et al. · Endocrine Practice
Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview
2026 · Joan Gil, Paula de Pedro-Campos, et al. · Machine Learning and Knowledge Extraction
PDF
New molecular markers of response to medical therapy in acromegaly
2025 · Aina Raventós, Joan Gil, et al. · Vitamins and hormones
Works count: 35
Citation count: 385
H-index: 11
I10-index: 14
Year
Topic
Type